Evidence map›Paper›PMID 27857681›Full record

ArticleFrontiers in neuroscience2016

Early Cytoskeletal Protein Modifications Precede Overt Structural Degeneration in the DBA/2J Mouse Model of Glaucoma.

Gina N Wilson, Matthew A Smith, Denise M Inman, Christine M Dengler-Crish, Samuel D Crish

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Posttranslational modifications of proteins in diseased retina.Frontiers in cellular neuroscience · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. The Role of Axonal Transport in Glaucoma.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Tryptophan Pathway Abnormalities in a Murine Model of Hereditary Glaucoma.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gina N WilsonDepartment of Pharmaceutical Sciences, Northeast Ohio Medical UniversityRootstown, OH, USA; School of Biomedical Sciences, Kent State UniversityKent, OH, USA.
Matthew A SmithDepartment of Pharmaceutical Sciences, Northeast Ohio Medical UniversityRootstown, OH, USA; Integrated Pharmaceutical Medicine Program, Northeast Ohio Medical UniversityRootstown, OH, USA.
Denise M InmanDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA.
Christine M Dengler-CrishDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA.
Samuel D CrishDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA.
Northeast Ohio Medical University · USKent State University · US

Funding

Axonopathy in GlaucomaR01EY022358 · NEI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CRISH, SAMUEL D · 2012 to 2016
$1.9M
NEI NIH HHS R01 EY022358
6 · The paper itself

Abstract

Axonal transport deficits precede structural loss in glaucoma and other neurodegenerations. Impairments in structural support, including modified cytoskeletal proteins, and microtubule-destabilizing elements, could be initiating factors in glaucoma pathogenesis. We investigated the time course of changes in protein levels and post-translational modifications in the DBA/2J mouse model of glaucoma. Using anterograde tract tracing of the retinal projection, we assessed major cytoskeletal and transported elements as a function of transport integrity in different stages of pathological progression. Using capillary-based electrophoresis, single- and multiplex immunosorbent assays, and immunofluorescence, we quantified hyperphosphorylated neurofilament-heavy chain, phosphorylated tau (ptau), calpain-mediated spectrin breakdown product (145/150 kDa), β-tubulin, and amyloid-β

Indexed as

amyloid-betaaxonal transportcytoskeletonglaucomaneurofilamentphosphorylationspectrintau

Identifiers

PMID27857681
PMCPMC5093131
OpenAlexW2547726227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.